MedElevator Войти в исследования
← Поиск публикаций

DOI 10.14661/2014.863-867

Медицинская библиотека · Electronic physician · 2014

Rhabdomyolysis due to Lamivudine administration in acute viral hepatitis B infection: a case report from Malaysia.

Baharin Janudin, Sahari Narisa Sulaiman, Lim Sazlyna Mohd Sazlly

СтатьяПеревод в очереди

Аннотация

Rhabdomyolysis is a serious but rare side effect of Lamivudine treatment. Therefore, appropriate biochemical monitoring should be undertaken when it is used in the treatment of hepatitis B. This paper presents a case of Lamivudine-associated rhabdomyolysis in a 31-year-old man with congenital heart disease and hepatitis B. Three days after starting Lamivudine, the patient developed myalgia. Significant muscle tenderness and swelling of the upper and lower limbs was discovered during a physical examination. Creatine kinase was markedly raised. Lamivudine-induced rhabdomyolysis was suspected and the drug was discontinued. Symptoms and creatine kinase activity improved within four days of Lamivudine cessation and hydration. Early identification of Lamivudine-induced rhabdomyolysis is key in preventing this potentially fatal drug reaction; withdrawal of Lamivudine may contribute to complete remission of rhabdomyolysis.

Для цитирования: Baharin Janudin, Sahari Narisa Sulaiman, Lim Sazlyna Mohd Sazlly. Rhabdomyolysis due to Lamivudine administration in acute viral hepatitis B infection: a case report from Malaysia.. Electronic physician. 2014. DOI: 10.14661/2014.863-867.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.